NMR relaxation studies with MnDPDP

Acta Radiologica

Volumn 38, Issue 4 PART 2, 1997, Pages 708-716

  Southon, T E ^a   Grant, Derek ^a   Bjornerud A ^a   Moen, O M ^a   Spilling, B ^a   Martinsen, I ^a   Refsum, H ^a  

^a NYCOMED IMAGING AS   (Norway)

Author keywords

Mangafodipir trisodium; Manganese; MR imaging, contrast media; NMR studies

Indexed keywords

CHLORIDE; CONTRAST MEDIUM; DRUG DERIVATIVE; EDETIC ACID; MANGANESE; MANGANESE CHLORIDE; MANGANESE DERIVATIVE; N,N' BIS(PYRIDOXAL 5 PHOSPHATE)ETHYLENEDIAMINE N,N' DIACETIC ACID; N,N'-BIS(PYRIDOXAL-5-PHOSPHATE)ETHYLENEDIAMINE-N,N'-DIACETIC ACID; PYRIDOXAL 5 PHOSPHATE;

ANIMAL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; COMPARATIVE STUDY; DOSE RESPONSE; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; SWINE; TIME; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; CHLORIDES; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EDETIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MANGANESE; MANGANESE COMPOUNDS; PYRIDOXAL PHOSPHATE; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ATOMIC; SWINE; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0031182189     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859709172403     Document Type: Article

References (24)

1. BABA Y., LERCH M. M., TANIMOTO A. et al.: Enhancement of pancreas and diagnosis of pancreatitis using manganese dipyridoxyl diphosphate. Invest. Radiol. Suppl. 29 (1994), S300.
2. GEHL H. B., VORWERK D., KLOSE K. C. & GUNTHER R. W.: Pancreatic enhancement after low-dose infusion of MnDPDP. Radiology 180 (1991), 337.
3. GRANT D., ZECH K. & HOLTZ E.: Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest. Radiol. Suppl. 29 (1994,) S249.
4. 2. Acta Radiol. 38 (1997), 740.
5. KANG Y. S. & GORE J. C.: Studies of tissue NMR relaxation enhancement by manganese. Invest. Radiol. 19 (1984), 399.
6. LARSEN L. E. & GRANT D.: General toxicology of MnDPDP. Acta Radiol. 38 (1997, 770.
7. LAUTERBUR P. C., MENDONCA-DIAS M. H. & RUDIN A. M.: Augmentation of tissue water proton spin-lattice relaxation rates by in-vivo addition of paramagnetic ions. In: Frontiers of biological energetics, vol. 1, p. 752. Edited by P. O. Dutton, J. S. Leigh & A. Scarpa. Academic Press, New York 1978.
8. LEANDER P., GOLMAN K., KLAVENESS J., HOLTZ E., OLSSON M. & LEUNBACH I.: MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction. Invest. Radiol. 25 (1990), 1130.
9. MAMOURIAN A. C., BURNETT K. R., GOLDSTEIN E. J., WOLF G. L., KRESSEL H. Y. & BAUM S.: Proton relaxation enhancement in tissue due to ingest manganese chloride. Time course and dose response in the rat. Physiol. Chem. Phys. Med. NMR 16 (1984), 123.
10. NELSON R. C., CHEZMAR J. L., NEWBERRY L. B., MALKO J. A. & BERNARDINO M. E.: Manganese dipyridoxyl diphosphate. Effect of dose, time and pulse sequence on hepatic enhancement in rats. Invest. Radiol. 26 (1991), 569.
11. NELSON R. C., CHEZMAR J. L., THOMPSON G. H. et al.: Magnetic resonance imaging after arterial portography with manganese dipyridoxyl diphosphate. Invest. Radiol. 28 (1993), 335.
12. 2. Acta Radiol. 38 (1997), 700.
13. RINCK P. A. & MULLER R. N.: Magnetic resonance imaging contrast agents. In: The rational use of magnetic resonance imaging, p. 287. Edited by P. A. Rinck. Blackwell Science, Oxford 1995.
14. ROFSKY N. M., WEINREB J. C., BERNADINO M. E., YOUNG S. W., LEE J. K. & NOZ M. E.: Hepatocellular tumors. Characterization with MnDPDP enhanced MR imaging. Radiology 188 (1993), 53.
15. RUMMENY E., EHRENHEIM C., GEHL H. B. et al.: Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients. Invest. Radiol. 26 Suppl. (1991), 142.
16. 2+. Magn. Reson. Med. 8 (1988), 293.
17. THORSTENSEN Ö., ISBERG B., JORULF H., WESTMAN L., SVAHN U. & VENIZELOS N.: MnDPDP enhancement in rabbit liver after intravenous bolus injection and slow infusion. Acta Radiol. 38 (1997), 717.
18. TOFT K. G., FRIISK, G. A. & SKOTLAND T.: Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging. Detection and quantitation of the parent compound MnDPDP and metabolites in human plasma by high performance liquid chromatography. J. Pharm. Biomed. Anal. 15 (1997), 973.
19. TOFT K. G., KINDBERG G. M. & SKOTLAND T: Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging. In vitro metabolism and protein binding studies of the active component MnDPDP in human blood. J. Pharm. Biomed. Anal. 15 (1997), 983.
20. TOFT K. G., HUSTVEDT S. O., GRANT D. et al.: Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol. 38 (1997), 677.
21. TORHEIM G. & RINCK P. A.: MR Image Expert - Interactively teaching contrast behaviour in magnetic resonance imaging. CAR Symposium 1996. Computer Assisted Radiology, p. 619. Elsevier Science Publ., Amsterdam 1996.
22. WANG C., GORDON P. B., HUSTVEDT S. O. et al.: MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol 38 (1997), 665.
23. WISNER E. R., MERISKO-LIVERSIDGE E., KELLAR K. et al.: Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver. Acad. Radiol. 2 (1995), 140.
24. WOLF G. L. & BAUM L.: Cardiovascular toxicity and tissue proton Tl response to manganese injection in the dog and rabbit. AJR 141 (1983), 193.